HOB Biotech Group Corp.,Ltd (688656.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
HOB Biotech Group Corp.,Ltd
Sector
Healthcare
Industry
Medical - Devices
Employees
529
First IPO Date
January 13, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Xiaohua Huang | Deputy General Manager | 0 | 1974 |
| Shuyan Han | Chief Financial Officer | 0 | 1980 |
| Chun Li Li | Accounting Supervisor | 0 | N/A |
| Qingxin Liu | Director & Deputy GM | 0 | 1974 |
| Ruoliang Sun | Deputy General Manager | 0 | 1972 |
| Aixiang Xie | Secretary | 0 | 1982 |
| John Li | Chairman & GM | 0 | 1963 |
AD
Description
HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.
AD
